Back
ESC Premium Access

PCSK9 inhibitor therapy and guideline treatment targets for cardiovascular disease and familial hypercholesterolaemia

Session: Pharmacology and pharmacotherapy e-posters
Topic: Lipid-Lowering Agents
Speaker: Mr A. Suresh (London, GB)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Mr Anirudh Suresh

Chelsea and Westminster Hospital NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

57 more presentations in this session

Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials

Speaker: Doctor J. Borovac (Split, HR)

Access
Abstract
Slides
Like
Thumbnail

The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus

Speaker: Doctor A. KANWAL (Valhalla, US)

Access
Abstract
Slides
Like
Thumbnail

Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.

Speaker: Doctor K. Dzaurova (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis

Speaker: Mrs A. Boulmpou (Thessaloniki, GR)

Access
Abstract
Slides
Like
Thumbnail

Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis

Speaker: Mrs A. Boulmpou (Thessaloniki, GR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Pharmacology and pharmacotherapy e-posters

Speakers: Mr A. Suresh, Doctor J. Borovac, Doctor A. KANWAL, Doctor K. Dzaurova, Mrs A. Boulmpou...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources